Published in Cell · View the paper (DOI)
Researchers at the German Center for Infection Research have developed effective antibodies against Pseudomonas aeruginosa, a major challenge in healthcare systems worldwide. These monoclonal antibodies target the pathogen's type III secretion system and show promise as a highly potent treatment option for acute and chronic infections.
Coverage from 2 institutions